These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9325329)

  • 61. Id helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF ETS-domain transcription factors.
    Yates PR; Atherton GT; Deed RW; Norton JD; Sharrocks AD
    EMBO J; 1999 Feb; 18(4):968-76. PubMed ID: 10022839
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of regulated phosphorylation in the biological activity of transcription factors SRF and Elk-1/SAP-1.
    Papavassiliou AG
    Anticancer Res; 1994; 14(5A):1923-6. PubMed ID: 7847828
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Critical Protein-Protein Interactions Determine the Biological Activity of Elk-1, a Master Regulator of Stimulus-Induced Gene Transcription.
    Thiel G; Backes TM; Guethlein LA; Rössler OG
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684708
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The mechanism of complex formation between Fli-1 and SRF transcription factors.
    Dalgleish P; Sharrocks AD
    Nucleic Acids Res; 2000 Jan; 28(2):560-9. PubMed ID: 10606656
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element.
    Dalton S; Treisman R
    Cell; 1992 Feb; 68(3):597-612. PubMed ID: 1339307
    [TBL] [Abstract][Full Text] [Related]  

  • 66. p38 Mitogen-activated protein kinase mediates the transcriptional induction of the atrial natriuretic factor gene through a serum response element. A potential role for the transcription factor ATF6.
    Thuerauf DJ; Arnold ND; Zechner D; Hanford DS; DeMartin KM; McDonough PM; Prywes R; Glembotski CC
    J Biol Chem; 1998 Aug; 273(32):20636-43. PubMed ID: 9685422
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Maximal serum stimulation of the c-fos serum response element requires both the serum response factor and a novel binding factor, SRE-binding protein.
    Boulden AM; Sealy LJ
    Mol Cell Biol; 1992 Oct; 12(10):4769-83. PubMed ID: 1328862
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Heparin and heparan sulfate inhibit extracellular signal-regulated kinase activation and myocardial cell hypertrophy induced by endothelin-1.
    Mizutani K; Kawashima S; Ueyama T; Sakoda T; Takeuchi S; Kobayashi S; Yokoyama M; Hayashi Y; Itoh H
    Kobe J Med Sci; 2001 Apr; 47(2):47-58. PubMed ID: 11599124
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ribosomal subunit kinase-2 is required for growth factor-stimulated transcription of the c-Fos gene.
    Bruning JC; Gillette JA; Zhao Y; Bjorbaeck C; Kotzka J; Knebel B; Avci H; Hanstein B; Lingohr P; Moller DE; Krone W; Kahn CR; Muller-Wieland D
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2462-7. PubMed ID: 10716983
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Activation of the human T-cell leukemia virus type 1 long terminal repeat by the ternary complex factor Elk-1.
    Winter HY; Dayaram T; Marriott SJ
    J Virol; 2007 Dec; 81(23):13075-81. PubMed ID: 17898074
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ras regulates the association of serum response factor and CCAAT/enhancer-binding protein beta.
    Hanlon M; Sealy L
    J Biol Chem; 1999 May; 274(20):14224-8. PubMed ID: 10318842
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of the effectiveness of DNA-binding drugs to inhibit transcription using the c-fos serum response element as a target.
    White CM; Heidenreich O; Nordheim A; Beerman TA
    Biochemistry; 2000 Oct; 39(40):12262-73. PubMed ID: 11015205
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular mechanisms for somatostatin inhibition of c-fos gene expression.
    Todisco A; Takeuchi Y; Yamada J; Sadoshima JI; Yamada T
    Am J Physiol; 1997 Apr; 272(4 Pt 1):G721-6. PubMed ID: 9142901
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term depression activates transcription of immediate early transcription factor genes: involvement of serum response factor/Elk-1.
    Lindecke A; Korte M; Zagrebelsky M; Horejschi V; Elvers M; Widera D; Prüllage M; Pfeiffer J; Kaltschmidt B; Kaltschmidt C
    Eur J Neurosci; 2006 Jul; 24(2):555-63. PubMed ID: 16903857
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Activation of the c-fos SRE through SAP-1a.
    Masutani H; Magnaghi-Jaulin L; Ait-Si-Ali S; Groisman R; Robin P; Harel-Bellan A
    Oncogene; 1997 Oct; 15(14):1661-9. PubMed ID: 9349499
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of a multiprotein complex interacting with the c-fos serum response element.
    de Belle I; Walker PR; Smith IC; Sikorska M
    Mol Cell Biol; 1991 May; 11(5):2752-9. PubMed ID: 1901946
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a.
    Janknecht R; Hunter T
    EMBO J; 1997 Apr; 16(7):1620-7. PubMed ID: 9130707
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The p38 and ERK MAP kinase pathways cooperate to activate Ternary Complex Factors and c-fos transcription in response to UV light.
    Price MA; Cruzalegui FH; Treisman R
    EMBO J; 1996 Dec; 15(23):6552-63. PubMed ID: 8978682
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Integration of MAP kinase signal transduction pathways at the serum response element.
    Whitmarsh AJ; Shore P; Sharrocks AD; Davis RJ
    Science; 1995 Jul; 269(5222):403-7. PubMed ID: 7618106
    [TBL] [Abstract][Full Text] [Related]  

  • 80. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.
    Chai Y; Chipitsyna G; Cui J; Liao B; Liu S; Aysola K; Yezdani M; Reddy ES; Rao VN
    Oncogene; 2001 Mar; 20(11):1357-67. PubMed ID: 11313879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.